Shield Therapeutics PLC operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shield Therapeutics PLC with three other
companies in this sector in the United Kingdom:
sales of £11.48 million [US$13.92 million]
of which 76%
was Research and development),
Tissue Regenix Group PLC
(£11.62 million [US$14.08 million]
of which 55%
was Orthopaedics), and
(£12.53 million [US$15.18 million]
of which 100%
was Medical Service).